Your session is about to expire
← Back to Search
Recovery Support for Bladder Cancer
N/A
Recruiting
Led By Michael Diefenbach, PhD
Research Sponsored by Northwell Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Did not need or completed neo-adjuvant chemotherapy
Undergoing bladder removal surgery and one of the following urinary diversions: 1) ileal conduit, 2) neobladder or 3) Indiana pouch
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
Study Summary
This trial will develop and evaluate a multi-stage intervention to help patients and caregivers prepare for surgery and recovery for those with bladder cancer.
Who is the study for?
This trial is for English-speaking men and women diagnosed with bladder cancer who are about to have their bladders removed and replaced with an artificial one (ileal conduit, neobladder, or Indiana pouch). They should not be in need of or already finished with neo-adjuvant chemotherapy. Caregivers must be in a stable caregiving role, not temporary.Check my eligibility
What is being tested?
The study tests a multi-stage intervention called Cancer Resource Information Support (CRIS) versus Usual Care Enhanced. CRIS includes pre-surgery preparation by nurses, stoma care training, and access to a recovery website with resources. The control group receives Facing Forward brochures from the National Cancer Institute.See study design
What are the potential side effects?
Since this trial focuses on educational support rather than medication, traditional side effects like those seen with drugs are not expected. However, participants may experience varying levels of emotional or psychological impact due to the nature of the information and support provided.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I did not need or have completed chemotherapy before surgery.
Select...
I am having my bladder removed and will get a new way to pass urine.
Select...
I can easily communicate in English.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Quality of Life Caregiver: The Caregiver Quality of Life Index-C
Urinary Bladder
Secondary outcome measures
Infection rate (biological factor)
Visiting Nurse/ER visits
Other outcome measures
Exploratory Cost Analysis
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Bladder cancer patients & caregivers receive standard instructions about post-op care from nursing staff plus access to Internet based software program, specifically designed for this research study. Software program contains relevant bladder cancer care instructions through videos, text, and graphics.
Group II: Usual care enhancedActive Control1 Intervention
Bladder cancer patients & caregivers receive standard instructions about post-op care from nursing staff plus the NCI published Facing forward cancer survivorship manual.
Find a Location
Who is running the clinical trial?
Northwell HealthLead Sponsor
458 Previous Clinical Trials
470,695 Total Patients Enrolled
1 Trials studying Patient Engagement
167 Patients Enrolled for Patient Engagement
Fox Chase Cancer CenterOTHER
227 Previous Clinical Trials
37,271 Total Patients Enrolled
Michael Diefenbach, PhDPrincipal Investigator - Northwell Health
Northwell Health
1 Previous Clinical Trials
138 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My caregiver is temporarily helping me.I did not need or have completed chemotherapy before surgery.I am having my bladder removed and will get a new way to pass urine.I have been diagnosed with breast cancer.I can easily communicate in English.
Research Study Groups:
This trial has the following groups:- Group 1: Usual care enhanced
- Group 2: Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there spots still available for volunteers to participate in this investigation?
"The current status of this research study, as per clinicaltrials.gov, is actively seeking participants; the initial posting being on October 1st 2018 and last amended on December 9th 2021."
Answered by AI
How many participants is the upper limit for this research endeavor?
"Affirmative, the information on clinicaltrials.gov demonstrates that this medical trial is actively seeking participants. The first posting was made on October 1st 2018 and revised as recently as December 9th 2021. 238 individuals need to be enrolled across 2 sites for the study's completion."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger